Clinical analysis of the outcome in pregnant patients with Antiphospholipid syndrome

杨京晶,梁梅英,王山米,张冲

DOI: https://doi.org/10.13390/j.issn.1672-1861.2014.01.012

2014-01-01

Abstract:Objective Characteristics of diagnosis and treatment for pregnancy with antiphospholipid syndrome were discussed.Methods The medical records of pregnant women with antiphospholipid syndrome were retrospectively collected between January 1990 and July 2013.Results Thirteen women with APS were included. Twelve of them were primary APS,one was secondary APS.Ten of these patients were diagnosed as APS before pregnancy,three of them were diagnosed during pregnancy.Eight patients had experienced frequent spontaneous abortions(61.54%).None of them had perinatal death.Among the pregnancies,eleven had term births preterm births(84.62%),two had preterm births(15.38%),Two had intrauterine growth retardation(15.38%).Treatment included low-dose aspirin(2 cases),low molecular heparin(3cases),low-dose aspirin and prednisone(3 cases),low molecular heparin and aspirin(3 cases),corticosteroid and gamma globulin(1 case)and gamma globulin alone(1 case).All of the patients were prescribed with oral low-dose aspirin or low molecular heparin after birth until six weeks postpartum.Conclusions Appropriate therapy can improve the pregnancy outcome of antiphospholipid syndrome patients.The diagnosis and relevent treatment deserve more value for patients without the medical history of antiphospholipid syndrome before pregnancy.